SPONSOR
Washington State University
Total Trials
3
Recruiting
3
Phases
EARLY_Phase 1, Phase 2
Washington State University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Interaction, Alcohol Use Disorder (AUD), Nicotine Use Disorder.
The trial portfolio spans EARLY_Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Washington State University
How many clinical trials has Washington State University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Washington State University, of which 3 are actively recruiting participants. These trials cover conditions including Interaction, Alcohol Use Disorder (AUD), Nicotine Use Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Washington State University research focus on?
Washington State University clinical trials span Interaction, Alcohol Use Disorder (AUD), Nicotine Use Disorder. The research pipeline includes EARLY_Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Washington State University clinical trial?
To participate in a Washington State University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Washington State University trials with current recruitment status updated daily.
Clinical Trials by Washington State University
NCT06693960 EARLY_Phase 1
Recruiting
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
Interaction
NCT06692933 EARLY_Phase 1
Recruiting
Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
Interaction
NCT05181891 Phase 2
Recruiting
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Alcohol Use Disorder (AUD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology